These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21446733)

  • 1. Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors.
    Feng L; Geisselbrecht Y; Blanck S; Wilbuer A; Atilla-Gokcumen GE; Filippakopoulos P; Kräling K; Celik MA; Harms K; Maksimoska J; Marmorstein R; Frenking G; Knapp S; Essen LO; Meggers E
    J Am Chem Soc; 2011 Apr; 133(15):5976-86. PubMed ID: 21446733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes.
    Maksimoska J; Feng L; Harms K; Yi C; Kissil J; Marmorstein R; Meggers E
    J Am Chem Soc; 2008 Nov; 130(47):15764-5. PubMed ID: 18973295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octahedral rhodium(III) complexes as kinase inhibitors: Control of the relative stereochemistry with acyclic tridentate ligands.
    Mollin S; Riedel R; Harms K; Meggers E
    J Inorg Biochem; 2015 Jul; 148():11-21. PubMed ID: 25660487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors.
    Bregman H; Carroll PJ; Meggers E
    J Am Chem Soc; 2006 Jan; 128(3):877-84. PubMed ID: 16417378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.
    Blanck S; Geisselbrecht Y; Kräling K; Middel S; Mietke T; Harms K; Essen LO; Meggers E
    Dalton Trans; 2012 Aug; 41(31):9337-48. PubMed ID: 22733119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iridium complex with antiangiogenic properties.
    Wilbuer A; Vlecken DH; Schmitz DJ; Kräling K; Harms K; Bagowski CP; Meggers E
    Angew Chem Int Ed Engl; 2010 May; 49(22):3839-42. PubMed ID: 20437440
    [No Abstract]   [Full Text] [Related]  

  • 9. Asymmetric catalysis mediated by the ligand sphere of octahedral chiral-at-metal complexes.
    Gong L; Chen LA; Meggers E
    Angew Chem Int Ed Engl; 2014 Oct; 53(41):10868-74. PubMed ID: 25156957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.
    Ma W; Guo L; Tian Z; Zhang S; He X; Li J; Yang Y; Liu Z
    Dalton Trans; 2019 Apr; 48(15):4788-4793. PubMed ID: 30892340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural analysis of PIM1 kinase complexes with ATP-competitive inhibitors.
    Bogusz J; Zrubek K; Rembacz KP; Grudnik P; Golik P; Romanowska M; Wladyka B; Dubin G
    Sci Rep; 2017 Oct; 7(1):13399. PubMed ID: 29042609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
    Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
    J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
    Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z
    Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal complexes as protein kinase inhibitors.
    Kunick C; Ott I
    Angew Chem Int Ed Engl; 2010 Jul; 49(31):5226-7. PubMed ID: 20589820
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework.
    Koch V; Meschkov A; Feuerstein W; Pfeifer J; Fuhr O; Nieger M; Schepers U; Bräse S
    Inorg Chem; 2019 Dec; 58(23):15917-15926. PubMed ID: 31714764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral-auxiliary-mediated asymmetric synthesis of ruthenium polypyridyl complexes.
    Gong L; Wenzel M; Meggers E
    Acc Chem Res; 2013 Nov; 46(11):2635-44. PubMed ID: 23730834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.
    Cánaves MM; Cabra MI; Bauzá A; Cañellas P; Sánchez K; Orvay F; García-Raso A; Fiol JJ; Terrón A; Barceló-Oliver M; Ballester P; Mata I; Molins E; Hussain F; Frontera A
    Dalton Trans; 2014 May; 43(17):6353-64. PubMed ID: 24599509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: Inhibition of PKA and a PKB Mimic.
    Lauber BS; Hardegger LA; Alam KA; Lund BA; Dumele O; Harder M; Kuhn B; Engh RA; Diederich F
    Chemistry; 2016 Jan; 22(1):211-21. PubMed ID: 26578105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.